Should we be worried about Covid this winter?
Experts are not too concerned about a new variant of Covid but say monitoring should continue.
Similar Posts
India pharma exports soaring despite cough syrup deaths, trade body says | Reuters News Agency
Health 25 July 2023, 6:19 pm 1 minute Reuters exclusively reported that India’s pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, a government-backed trade body told Reuters, despite deaths linked to Indian-made cough syrups. Market Impact…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
AI, wearables and more — these markets are booming as the world ages. The pros share 4 stock picks
The world is aging rapidly, and there are more and more ways to invest in this theme. Shams Afzal, managing director at Carnegie Investment Counsel, noted that 17% of the U.S. population is now over the age of 65, and that proportion is expected to grow higher. And the demographics of that age group is…
Kratom faces scrutiny over health risks
Kratom faces scrutiny over health risks – CBS News Watch CBS News Kratom is commonly marketed as a health wonder, but the FDA warns of “serious adverse effects.” It has even been blamed for several deaths. Mark Strassmann reports. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting….
Are COVID-19 symptoms still the same? What to know about this winter’s JN.1 wave
Reports of respiratory illness have now reached “high” or “very high” levels across at least 16 state or big city health departments, the Centers for Disease Control and Prevention said, as trends of COVID-19 and influenza have accelerated in many parts of the country. And while a fast-growing new COVID variant called JN.1 is estimated…
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
